Clinical Trial Update: Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial updating the use of Imatinib Mesylate with combination chemotherapy, with or without donor stem cell transplant, in newly diagnosed acute lymphobl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Imatinib mesylate (Imatinib)

Snippet

Sponsor: Asan Medical Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED